Cognition after carotid endarterectomy or stenting: a randomized comparison
A Altinbas1, M J E van Zandvoort, E van den Berg
1Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, PO Box 85500, G03.228, 3508 GA Utrecht, the Netherlands. a.altinbas@umcutrecht.nl
Neurology
|September 2, 2011
Summary
Carotid artery stenting (CAS) and carotid endarterectomy (CEA) showed no significant cognitive differences. However, CAS procedures resulted in more new ischemic brain lesions compared to CEA.
Area of Science:
- Neurology
- Interventional Cardiology
- Neurosurgery
Background:
- Symptomatic carotid artery stenosis poses a risk of stroke.
- Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are revascularization procedures to mitigate this risk.
- The comparative effects of CAS and CEA on cognitive function remain an area of investigation.
Purpose of the Study:
- To compare the impact of CAS versus CEA on cognitive function in patients with symptomatic carotid artery stenosis.
- To assess the incidence of new ischemic brain lesions following CAS and CEA.
Main Methods:
- A substudy of the International Carotid Stenting Study (ICSS) involving 140 patients with detailed neuropsychological examinations (NPE) before and 6 months after revascularization.
- Diffusion-weighted imaging was used to detect ischemic brain lesions within 3 days post-revascularization.
- Cognitive test results were standardized into z scores to calculate a cognitive sumscore for primary outcome analysis.
Main Results:
- While CAS was associated with a greater decrease in cognition than CEA, the difference was not statistically significant (p = 0.092).
- New ischemic brain lesions were detected significantly more often after CAS compared to CEA (RR 2.1, p = 0.041).
- Of 120 patients with follow-up NPE, 64 had post-revascularization MRI, revealing a higher lesion rate in the CAS group.
Conclusions:
- The study found no statistically significant difference in cognitive outcomes between CAS and CEA at 6 months.
- Despite similar cognitive effects, CAS was associated with a substantially higher rate of new ischemic lesions.
- Class III evidence suggests any cognitive difference between CAS and CEA is small.

